Proteome Sciences

The multiplexed proteomic approach could offer better sensitivity and accuracy than existing methods while working with a wider range of instrumentation.

The approach uses isobaric tagging to quantify proteins in single cells, and is one of the first to bring mass spec analysis to the single-cell level.

The company plans to use the money to speed its transition to a contract research business model, and to support its TMT reagents business.

The company hopes that looking at multiple species of the phosphorylated tau protein could allow for earlier and more accurate diagnosis of the disease.

The company, which has struggled to turn its broad proteomics expertise into steady profits, plans to focus more tightly on its pharma services business.

The firm is placing about 13.9 million new shares of its stock at 18 pence per share. 

The UK-based proteomics and lipidomics firm will offer solutions to help healthcare professionals utilizing protein expression data in patient care. 

Proteome Sciences this week lowered its full year 2014 guidance, citing delays in the timing of several contracts.

Proteome Sciences appointed Martin Diggle to its board as a non-executive director. Diggle is a director and partner at Vulpes Investment Management, where he manages the Vulpes Life Sciences Fund, which holds roughly 16 percent of Proteome Sciences’ ordinary shares.

NEW YORK (GenomeWeb News) – Proteome Sciences today said that revenues for the first half of 2014 were down 12 percent year over year.

Pages

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.